Evaluation of safety of insulin degludec on undergoing total-colonoscopy using continuous glucose monitoring
Not Applicable
- Conditions
- type 2 diabetes mellitus colon cancer
- Registration Number
- JPRN-UMIN000012265
- Lead Sponsor
- Ichinomiyanishi Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
1) severe renal dysfunction (serum creatinine level over 2.0 mg/dL) 2) judged to be unsuitable for participation for medical reasons
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method